» Articles » PMID: 3553852

Acute Elevation of Free Fatty Acid Levels Leads to Hepatic Insulin Resistance in Obese Subjects

Overview
Journal Metabolism
Specialty Endocrinology
Date 1987 May 1
PMID 3553852
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Raised levels of free fatty acids (FFA) compete with glucose for utilization by insulin-sensitive tissues, and, therefore, they may induce insulin resistance in the normal subject. The influence of experimental elevations in FFA levels on glucose metabolism in native insulin-resistant states is not known. We studied seven women with moderate obesity (63% above their ideal body weight) but normal glucose tolerance with the use of the insulin clamp technique with or without an infusion of Intralipid + heparin. Upon raising plasma insulin levels to approximately 60 microU/mL while maintaining euglycemia, whole body glucose utilization (3H-3-glucose) rose similarly without (from 66 +/- 7 to 113 +/- 11 mg/min m2, P less than .02) or with (from 70 +/- 7 to 137 +/- 19 mg/min m2, P less than .02) concomitant lipid infusion. In contrast, endogenous glucose production was considerably (73%) suppressed (from 66 +/- 7 to 15 +/- 8 mg/min m2, P less than .001) during the clamp without lipid, but declined only marginally (from 70 +/- 7 to 48 +/- 7 mg/min m2, NS) with lipid administration. The difference between the control and the lipid study was highly significant (P less than .02), and amounted to an average of 3.8 g of relative glucose overproduction during the second hour of the clamp. Blood levels of lactate rose by 34 +/- 15% (.1 greater than P greater than .05) in the control study but only by 17 +/- 10% (NS) during lipid infusion. Blood pyruvate concentrations fell in both sets of experiments (by approximately 45% at the end of the study) with similar time courses.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

White adipocyte dysfunction and obesity-associated pathologies in humans.

Hagberg C, Spalding K Nat Rev Mol Cell Biol. 2023; 25(4):270-289.

PMID: 38086922 DOI: 10.1038/s41580-023-00680-1.


Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.

Palermo N, Sadhu A, McDonnell M J Clin Endocrinol Metab. 2020; 105(8).

PMID: 32556147 PMC: 7337869. DOI: 10.1210/clinem/dgaa360.


Fructose and hepatic insulin resistance.

Softic S, Stanhope K, Boucher J, Divanovic S, Lanaspa M, Johnson R Crit Rev Clin Lab Sci. 2020; 57(5):308-322.

PMID: 31935149 PMC: 7774304. DOI: 10.1080/10408363.2019.1711360.


Visceral fat reduction is positively associated with blood pressure reduction in overweight or obese males but not females: an observational study.

Guo X, Xu Y, He H, Cai H, Zhang J, Li Y Nutr Metab (Lond). 2019; 16:44.

PMID: 31320919 PMC: 6617559. DOI: 10.1186/s12986-019-0369-0.


TNF- Downregulation Modifies Insulin Receptor Substrate 1 (IRS-1) in Metabolic Signaling of Diabetic Insulin-Resistant Hepatocytes.

Alipourfard I, Datukishvili N, Mikeladze D Mediators Inflamm. 2019; 2019:3560819.

PMID: 30863203 PMC: 6378771. DOI: 10.1155/2019/3560819.